Beijing Foyou Pharma CO.,LTD (SHA:601089)

SHA:601089 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	3,407	3,433	3,328	3,237	2,838	2,535
Other Revenue	12.36	12.36	11.97	3.15	-	-
Revenue	3,419	3,446	3,340	3,240	2,838	2,535
Revenue Growth (YoY)	-0.13%	3.17%	3.07%	14.18%	11.93%	4.56%
Cost of Revenue	1,165	1,145	1,128	1,040	874.82	733.76
Gross Profit	2,255	2,301	2,212	2,200	1,963	1,802
Selling, General & Admin	1,342	1,392	1,353	1,492	1,403	1,341
Research & Development	396.62	417.37	353.33	238.4	176.87	138.16
Other Operating Expenses	35.48	21.85	26.27	34.56	30.43	23.62
Operating Expenses	1,776	1,833	1,730	1,767	1,608	1,504
Operating Income	479.05	468.41	481.62	432.97	354.75	297.35
Interest Expense	-1.97	-3.5	-5.34	-4.76	-6.51	-11.1
Interest & Investment Income	34.12	49.25	58.02	35.83	7.98	6.05
Currency Exchange Gain (Loss)	0.37	0.37	0.05	0.39	-0.06	-0.23
Other Non Operating Income (Expenses)	-3.46	-0.63	-0.68	-1.18	-2.48	-1.01
EBT Excluding Unusual Items	508.11	513.91	533.67	463.25	353.68	291.05
Gain (Loss) on Sale of Assets	-7.28	1.04	0.23	0.14	0.01	-0.65
Asset Writedown	-1.32	-	-	-	-1.13	-10.39
Legal Settlements	-	-	-	-	-0.54	-
Other Unusual Items	25.17	25.17	15.26	22.56	13.67	19.77
Pretax Income	524.68	540.12	549.15	485.95	365.69	299.78
Income Tax Expense	58.89	48.04	56.81	46.33	49.79	35.28
Earnings From Continuing Operations	465.79	492.08	492.34	439.62	315.91	264.5
Minority Interest in Earnings	-2.72	-3.4	-3.57	-0.72	-1.44	-1.79
Net Income	463.07	488.67	488.77	438.9	314.47	262.71
Net Income to Common	463.07	488.67	488.77	438.9	314.47	262.71
Net Income Growth	-9.20%	-0.02%	11.36%	39.57%	19.70%	20.09%
Shares Outstanding (Basic)	477	470	479	422	361	360
Shares Outstanding (Diluted)	477	470	479	422	361	360
Shares Change (YoY)	0.96%	-1.94%	13.55%	16.75%	0.44%	0.35%
EPS (Basic)	0.97	1.04	1.02	1.04	0.87	0.73
EPS (Diluted)	0.97	1.04	1.02	1.04	0.87	0.73
EPS Growth	-10.07%	1.96%	-1.92%	19.54%	19.18%	19.67%
Free Cash Flow	58.85	299.23	189.82	524.36	335.05	217.69
Free Cash Flow Per Share	0.12	0.64	0.40	1.24	0.93	0.60
Dividend Per Share	0.500	0.500	0.500	0.400	0.300	0.300
Dividend Growth	-	-	25.00%	33.33%	-	-
Gross Margin	65.94%	66.78%	66.22%	67.91%	69.17%	71.06%
Operating Margin	14.01%	13.59%	14.42%	13.36%	12.50%	11.73%
Profit Margin	13.54%	14.18%	14.64%	13.55%	11.08%	10.36%
Free Cash Flow Margin	1.72%	8.68%	5.68%	16.18%	11.81%	8.59%
EBITDA	565.47	551.98	561.39	499.93	413.17	341.56
EBITDA Margin	16.54%	16.02%	16.81%	15.43%	14.56%	13.47%
D&A For EBITDA	86.42	83.57	79.77	66.96	58.42	44.22
EBIT	479.05	468.41	481.62	432.97	354.75	297.35
EBIT Margin	14.01%	13.59%	14.42%	13.36%	12.50%	11.73%
Effective Tax Rate	11.22%	8.89%	10.35%	9.53%	13.61%	11.77%
Revenue as Reported	3,419	3,446	3,340	3,240	-	-
Advertising Expenses	-	37.65	45.32	25.17	26.19	20.97

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.